how about some positive news?, page-2

Thompson, I can understand your anguish. I'm feeling it too. I think that it would be a very good outcome if the sale to Aspen falls flat. I believe that the Pharmaceuticals division has great potential into the future with many new drugs coming off patent. In my opinion, the best outcome for long-term shareholders is if the sale doesn't go through and the company rebuilds. The sale to Aspen is only of benefit to short/mid-term shareholders who bought in at recent lows.